Incentives and Reminders to Improve Long-term Medication Adherence (INMIND): Protocol for a Pilot Randomized Controlled Trial

Chad Stecher, Ishita Ghai, Lillian Lunkuse, Peter Wabukala, Mary Odiit, Agnes Nakanwagi, Sebastian Linnemayr, Chad Stecher, Ishita Ghai, Lillian Lunkuse, Peter Wabukala, Mary Odiit, Agnes Nakanwagi, Sebastian Linnemayr

Abstract

Background: Nonadherence to antiretroviral therapy (ART) among people living with HIV is a crucial barrier to attaining viral suppression globally. Existing behavioral interventions have successfully increased ART adherence, but typically show only short-term impact that dissipates after the interventions are withdrawn.

Objective: This study aims to test the feasibility, acceptability, and preliminary efficacy of a novel intervention that uses SMS text messages and conditional incentives to support ART initiators in establishing pill-taking habits.

Methods: A sample of 150 participants aged ≥18 years who have initiated ART in the preceding 3 months will be recruited from Mildmay Uganda in Kampala, Uganda. All (150/150, 100%) participants will be educated on the anchoring strategy and will choose an existing routine to pair with their daily ART adherence from a set of 3 suggested routines: getting dressed in the morning, eating breakfast, or eating dinner. Then, participants will be randomized to receive either usual care (control group: 50/150, 33.3%) or 1 of the 2 interventions delivered over 3 months: daily SMS text message reminders to follow their chosen anchoring plan (messages group; treatment group 1: 50/150, 33.3%) or daily SMS text messages and incentives conditional on taking their ART medication around the time of their chosen anchor (incentives group; treatment group 2: 50/150, 33.3%). Long-term ART adherence will be evaluated for 6 months after the intervention, and survey assessments will be conducted at baseline, 3 months, and 9 months. Outcomes include feasibility and acceptability measures and intervention efficacy outcomes defined by electronically measured mean medication adherence during the intervention and during the 6 months after the intervention, along with a measure of routine ART adherence based on taking medications around the time of participants' anchor during the intervention and during the 6 months after intervention.

Results: As of February 18, 2022, recruitment was completed. A total of 150 participants were recruited, and data collection is expected to end in December of 2022. Final results are expected to be submitted for publication by April 2023.

Conclusions: This study is the first to use behavioral economics-based interventions in combination with the anchoring strategy to improve long-term ART adherence among treatment initiators. We hypothesize that the combination of SMS text message reminders and incentives will increase participants' use of their anchoring strategy, and thus medication adherence will be better maintained after the intervention ends in our intervention groups relative to the control group that uses only the anchoring strategy. Results of this pilot study will help to refine this combined intervention approach for testing at scale and broaden our understanding of the habit formation process.

Trial registration: ClinicalTrials.gov NCT05131165; https://ichgcp.net/clinical-trials-registry/NCT05131165.

International registered report identifier (irrid): DERR1-10.2196/42216.

Keywords: HIV; antiretroviral therapy; behavioral economics; habit formation; medication adherence; routines.

Conflict of interest statement

Conflicts of Interest: None declared.

©Chad Stecher, Ishita Ghai, Lillian Lunkuse, Peter Wabukala, Mary Odiit, Agnes Nakanwagi, Sebastian Linnemayr. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 31.10.2022.

Figures

Figure 1
Figure 1
Depiction of the habit formation model by Duhigg [21] that underlies the anchoring intervention strategy, which we propose to enhance in Incentives and Reminders to Improve Long-term Medication Adherence (INMIND) through incentives and reminders to successfully routinize antiretroviral therapy (ART) adherence among patients with HIV. BE: behavioral economics.
Figure 2
Figure 2
Schedule of enrollment, interventions, and assessments (SPIRIT [Standard Protocol Items: Recommendations for Interventional Trials] figure). MEMS: medication event monitoring system; T1: treatment group 1; T2: treatment group 2.

References

    1. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–60. doi: 10.1056/NEJM199803263381301.
    1. Parienti JJ, Ragland K, Lucht F, de la Blanchardière A, Dargère S, Yazdanpanah Y, Dutheil JJ, Perré P, Verdon R, Bangsberg DR, ESPOIR and REACH study groups Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis. 2010 Apr 15;50(8):1192–7. doi: 10.1086/651419.
    1. Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011 Mar;45(3):372–9. doi: 10.1345/aph.1P587.aph.1P587
    1. Pasternak AO, de Bruin M, Jurriaans S, Bakker M, Berkhout B, Prins JM, Lukashov VV. Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012 Nov;206(9):1443–52. doi: 10.1093/infdis/jis502.jis502
    1. AIDSinfo. Joint United Nations Programme on HIV/AIDS. 2017. [2019-11-06].
    1. Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, Mills EJ, Gross R. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011 Apr;11(2):167–74. doi: 10.2174/187152611795589663. BSP/ ID DT /E-Pub/-00010-11-2
    1. May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C, UK Collaborative HIV Cohort (UK CHIC) Study Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014 May 15;28(8):1193–202. doi: 10.1097/QAD.0000000000000243.
    1. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007 May;19(5):658–65. doi: 10.1080/09540120701244943.778664177
    1. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010 Aug;14(4):778–84. doi: 10.1007/s10461-009-9533-2.
    1. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005 Jan;16(1):38–41. doi: 10.1258/0956462052932548.
    1. Gallant JE. Strategies for long-term success in the treatment of HIV infection. JAMA. 2000 Mar 08;283(10):1329–34. doi: 10.1001/jama.283.10.1329.jgh90001
    1. Shuter J, Sarlo JA, Stubbs RO, Rode RA, Zingman BS. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic) 2012;11(2):94–7. doi: 10.1177/1545109711420498.1545109711420498
    1. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011 Oct;15(7):1381–96. doi: 10.1007/s10461-011-9942-x.
    1. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011 Mar 15;52(6):793–800. doi: 10.1093/cid/ciq243. ciq243
    1. Alison Phillips L, Leventhal H, Leventhal EA. Assessing theoretical predictors of long-term medication adherence: patients' treatment-related beliefs, experiential feedback and habit development. Psychol Health. 2013;28(10):1135–51. doi: 10.1080/08870446.2013.793798.
    1. Brooks TL, Leventhal H, Wolf MS, O'Conor R, Morillo J, Martynenko M, Wisnivesky JP, Federman AD. Strategies used by older adults with asthma for adherence to inhaled corticosteroids. J Gen Intern Med. 2014 Nov;29(11):1506–12. doi: 10.1007/s11606-014-2940-8.
    1. Wood W, Neal DT. A new look at habits and the habit-goal interface. Psychol Rev. 2007 Oct;114(4):843–63. doi: 10.1037/0033-295X.114.4.843.2007-13558-001
    1. Lally P, Gardner B. Promoting habit formation. Health Psychol Rev. 2013 May;7(sup1):S137–58. doi: 10.1080/17437199.2011.603640.
    1. Rothman AJ, Sheeran P, Wood W. Reflective and automatic processes in the initiation and maintenance of dietary change. Ann Behav Med. 2009 Dec;38 Suppl 1:S4–17. doi: 10.1007/s12160-009-9118-3.
    1. Redish AD, Jensen S, Johnson A. Addiction as vulnerabilities in the decision process. Behav Brain Sci. 2008 Jul 29;31(4):461–87. doi: 10.1017/S0140525X08004986. S0140525X0800472X
    1. Duhigg C. The Power of Habit: Why We Do What We Do, and How to Change. New York, NY, USA: Random House; 2013.
    1. Pfeffer I, Strobach T. Behavioural automaticity moderates and mediates the relationship of trait self-control and physical activity behaviour. Psychol Health. 2018 Jul;33(7):925–40. doi: 10.1080/08870446.2018.1436176.
    1. Gardner B. A review and analysis of the use of 'habit' in understanding, predicting and influencing health-related behaviour. Health Psychol Rev. 2015;9(3):277–95. doi: 10.1080/17437199.2013.876238.
    1. Rothman AJ, Gollwitzer PM, Grant AM, Neal DT, Sheeran P, Wood W. Hale and hearty policies: how psychological science can create and maintain healthy habits. Perspect Psychol Sci. 2015 Nov;10(6):701–5. doi: 10.1177/1745691615598515.10/6/701
    1. Park DC, Kidder DP. Prospective memory and medication adherence. In: Brandimonte M, Einstein GO, McDaniel MA, editors. Prospective Memory: Theory and Applications. New York, NY, USA: Lawrence Erlbaum Associates; 1996. pp. 369–90.
    1. Prestwich A, Lawton R, Conner M. The use of implementation intentions and the decision balance sheet in promoting exercise behaviour. Psychol Health. 2003 Dec;18(6):707–21. doi: 10.1080/08870440310001594493.
    1. Achtziger A, Gollwitzer PM, Sheeran P. Implementation intentions and shielding goal striving from unwanted thoughts and feelings. Pers Soc Psychol Bull. 2008 Mar;34(3):381–93. doi: 10.1177/0146167207311201.34/3/381
    1. Armitage CJ, Arden MA. How useful are the stages of change for targeting interventions? Randomized test of a brief intervention to reduce smoking. Health Psychol. 2008 Nov;27(6):789–98. doi: 10.1037/0278-6133.27.6.789.2008-16224-015
    1. Sheeran P, Orbell S. Implementation intentions and repeated behaviour: augmenting the predictive validity of the theory of planned behaviour. Eur J Soc Psychol. 1999 Mar;29(2-3):349–69. doi: 10.1002/(sici)1099-0992(199903/05)29:2/3<349::aid-ejsp931>;2-y.
    1. Lally P, Chipperfield A, Wardle J. Healthy habits: efficacy of simple advice on weight control based on a habit-formation model. Int J Obes (Lond) 2008 Apr;32(4):700–7. doi: 10.1038/sj.ijo.0803771.0803771
    1. Gardner B, de Bruijn GJ, Lally P. A systematic review and meta-analysis of applications of the Self-Report Habit Index to nutrition and physical activity behaviours. Ann Behav Med. 2011 Oct;42(2):174–87. doi: 10.1007/s12160-011-9282-0.
    1. Verplanken B, Faes S. Good intentions, bad habits, and effects of forming implementation intentions on healthy eating. Eur J Soc Psychol. 1999 Aug;29(5-6):591–604. doi: 10.1002/(sici)1099-0992(199908/09)29:5/6<591::aid-ejsp948>;2-h.
    1. Beeken RJ, Croker H, Morris S, Leurent B, Omar R, Nazareth I, Wardle J. Study protocol for the 10 Top Tips (10TT) trial: randomised controlled trial of habit-based advice for weight control in general practice. BMC Public Health. 2012 Aug 16;12:667. doi: 10.1186/1471-2458-12-667. 1471-2458-12-667
    1. Enriquez M, McKinsey DS. Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV AIDS (Auckl) 2011;3:45–51. doi: 10.2147/HIV.S8993. doi: 10.2147/HIV.S8993.hiv-3-045
    1. Gardner B, Sheals K, Wardle J, McGowan L. Putting habit into practice, and practice into habit: a process evaluation and exploration of the acceptability of a habit-based dietary behaviour change intervention. Int J Behav Nutr Phys Act. 2014 Oct 30;11:135. doi: 10.1186/s12966-014-0135-7. s12966-014-0135-7
    1. O'Donoghue T, Rabin M. Present bias: lessons learned and to be learned. Am Econ Rev. 2015 May 01;105(5):273–9. doi: 10.1257/aer.p20151085.
    1. Chetty R, Looney A, Kroft K. Salience and taxation: theory and evidence. Am Econ Rev. 2009 Aug 01;99(4):1145–77. doi: 10.1257/aer.99.4.1145.
    1. Mantzari E, Vogt F, Shemilt I, Wei Y, Higgins JP, Marteau TM. Personal financial incentives for changing habitual health-related behaviors: a systematic review and meta-analysis. Prev Med. 2015 Jun;75:75–85. doi: 10.1016/j.ypmed.2015.03.001. S0091-7435(15)00072-9
    1. Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008 Dec 10;300(22):2631–7. doi: 10.1001/jama.2008.804. 300/22/2631
    1. Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, Kimmel SE. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008 Dec 23;8:272. doi: 10.1186/1472-6963-8-272. 1472-6963-8-272
    1. Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77(3):909–31. doi: 10.3982/ecta7416.
    1. Dai H, Milkman KL, Riis J. The fresh start effect: temporal landmarks motivate aspirational behavior. Manag Sci. 2014 Oct;60(10):2563–82. doi: 10.1287/mnsc.2014.1901.
    1. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, Amzel A, Fogg KP. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One. 2014 Nov 5;9(11):e111421. doi: 10.1371/journal.pone.0111421. PONE-D-14-14916
    1. Buscher A, Hartman C, Kallen MA, Giordano TP. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS. 2012 May;23(5):351–5. doi: 10.1258/ijsa.2011.011292. 23/5/351
    1. Linnemayr S, Stecher C, Mukasa B. Behavioral economic incentives to improve adherence to antiretroviral medication. AIDS. 2017 Mar 13;31(5):719–26. doi: 10.1097/QAD.0000000000001387. 00002030-201703130-00013
    1. Cramer J, Vachon L, Desforges C, Sussman NM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia. 1995 Nov;36(11):1111–7. doi: 10.1111/j.1528-1157.1995.tb00469.x.
    1. Gardner B, Abraham C, Lally P, de Bruijn GJ. Towards parsimony in habit measurement: testing the convergent and predictive validity of an automaticity subscale of the Self-Report Habit Index. Int J Behav Nutr Phys Act. 2012 Aug 30;9:102. doi: 10.1186/1479-5868-9-102. 1479-5868-9-102
    1. Verplanken B, Orbell S. Reflections on past behavior: a self-report index of habit strength. J Appl Soc Psychol. 2003 Jun;33(6):1313–30. doi: 10.1111/j.1559-1816.2003.tb01951.x.
    1. Falk A, Becker A, Dohmen T, Enke B, Huffman D, Sunde U. Global evidence on economic preferences. Q J Econ. 2018 Nov;133(4):1645–92. doi: 10.1093/qje/qjy013.
    1. Deci EL, Ryan RM. Intrinsic motivation. In: Weiner IB, Craighead WE, editors. The Corsini Encyclopedia of Psychology. Hoboken, NJ, USA: Wiley Online Library; 2010.
    1. Stecher C, Mukasa B, Linnemayr S. Uncovering a behavioral strategy for establishing new habits: evidence from incentives for medication adherence in Uganda. J Health Econ. 2021 May;77:102443. doi: 10.1016/j.jhealeco.2021.102443. S0167-6296(21)00028-X
    1. Wood W, Neal DT. Healthy through habit: interventions for initiating and maintaining health behavior change. Behav Sci Policy. 2016;2(1):71–83. doi: 10.1353/bsp.2016.0008.
    1. Galla BM, Duckworth AL. More than resisting temptation: beneficial habits mediate the relationship between self-control and positive life outcomes. J Pers Soc Psychol. 2015 Sep;109(3):508–25. doi: 10.1037/pspp0000026. 2015-03943-001
    1. Sheeran P. Intention—behavior relations: a conceptual and empirical review. Eur Rev Soc Psychol. 2002 Jan;12(1):1–36. doi: 10.1080/14792772143000003.
    1. Linnemayr S. Behavioral economics and HIV: a review of existing studies and potential future research areas. In: Hanoch Y, Barnes AJ, Rice T, editors. Behavioral Economics and Healthy Behaviors: Key Concepts and Current Research. London, UK: Routledge; 2017. pp. 141–56.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe